BDNF and Alzheimer disease: In addition, oral administration of nattokinase in a rat model of AD showed a significant decrease in brain levels of apoptotic and inflammatory factors, and an increase in brain-derived neurotrophic factor and insulin-like growth factor-1 levels when compared with untreated AD-induced rats [19].